Tower Research Capital LLC (Trc) Gossamer Bio, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.39 Billion
Q3 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 12,948 shares of GOSS stock, worth $35,089. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,948

Previous 2,249 475.72%

Holding current value

$35,089

Previous $2,000 1600.0%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$1.21 - $3.46 $12,945 - $37,018	10,699 Added 475.72%	12,948 $34,000
Q2 2025 Aug 14, 2025	SELL	$0.78 - $1.44 $2,250 - $4,154	-2,885 Reduced 56.19%	2,249 $2,000
Q1 2025 May 15, 2025	BUY	$0.85 - $1.53 $4,363 - $7,855	5,134 New	5,134 $5,000
Q3 2024 Nov 14, 2024	SELL	$0.79 - $1.25 $11,249 - $17,800	-14,240 Reduced 76.17%	4,456 $4,000
Q2 2024 Aug 13, 2024	BUY	$0.51 - $1.27 $712 - $1,775	1,398 Added 8.08%	18,696 $16,000

Q1 2024 May 15, 2024	BUY	$0.8 - $1.51 $9,996 - $18,868	12,496 Added 260.22%	17,298 $20,000
Q4 2023 Feb 13, 2024	SELL	$0.48 - $1.08 $12,169 - $27,382	-25,354 Reduced 84.08%	4,802 $4,000
Q3 2023 Nov 14, 2023	BUY	$0.78 - $1.82 $6,484 - $15,129	8,313 Added 38.06%	30,156 $25,000
Q2 2023 Aug 14, 2023	SELL	$0.98 - $1.53 $69,181 - $108,007	-70,593 Reduced 76.37%	21,843 $26,000
Q1 2023 May 09, 2023	BUY	$0.96 - $2.92 $22,606 - $68,760	23,548 Added 34.18%	92,436 $116,000
Q4 2022 Feb 10, 2023	BUY	$1.74 - $12.87 $92,394 - $683,397	53,100 Added 336.33%	68,888 $149,000
Q3 2022 Nov 10, 2022	BUY	$7.21 - $14.88 $92,662 - $191,237	12,852 Added 437.74%	15,788 $189,000
Q2 2022 Aug 15, 2022	SELL	$5.97 - $9.97 $31,730 - $52,990	-5,315 Reduced 64.42%	2,936 $25,000
Q1 2022 May 12, 2022	BUY	$8.44 - $12.49 $45,576 - $67,446	5,400 Added 189.41%	8,251 $71,000
Q4 2021 Feb 14, 2022	SELL	$10.12 - $14.07 $47,027 - $65,383	-4,647 Reduced 61.98%	2,851 $32,000
Q3 2021 Nov 15, 2021	SELL	$7.25 - $13.23 $10,396 - $18,971	-1,434 Reduced 16.05%	7,498 $94,000
Q2 2021 Aug 16, 2021	BUY	$8.0 - $9.75 $53,296 - $64,954	6,662 Added 293.48%	8,932 $72,000
Q1 2021 May 17, 2021	SELL	$8.63 - $10.94 $14,567 - $18,466	-1,688 Reduced 42.65%	2,270 $21,000
Q4 2020 Feb 16, 2021	BUY	$8.3 - $13.59 $14,325 - $23,456	1,726 Added 77.33%	3,958 $38,000
Q3 2020 Nov 16, 2020	SELL	$11.3 - $14.75 $63,133 - $82,408	-5,587 Reduced 71.45%	2,232 $28,000
Q2 2020 Aug 13, 2020	BUY	$9.52 - $15.98 $74,436 - $124,947	7,819 New	7,819 $102,000
Q1 2020 May 15, 2020	SELL	$8.0 - $15.48 $13,664 - $26,439	-1,708 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$14.82 - $26.79 $186,050 - $336,321	-12,554 Reduced 88.02%	1,708 $27,000
Q3 2019 Nov 05, 2019	BUY	$16.02 - $22.47 $228,477 - $320,467	14,262 New	14,262 $239,000
Q2 2019 Aug 13, 2019	SELL	$16.12 - $22.89 $1,902 - $2,701	-118 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$17.58 - $23.97 $2,074 - $2,828	118 New	118 $3,000

Others Institutions Holding GOSS

# of Institutions

181

Shares Held

163M

Call Options Held

8.11M

Put Options Held

211K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $255M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Gossamer Bio, Inc. Transaction History